188 related articles for article (PubMed ID: 29453336)
1. Alternative splicing of ALCAM enables tunable regulation of cell-cell adhesion through differential proteolysis.
Hebron KE; Li EY; Arnold Egloff SA; von Lersner AK; Taylor C; Houkes J; Flaherty DK; Eskaros A; Stricker TP; Zijlstra A
Sci Rep; 2018 Feb; 8(1):3208. PubMed ID: 29453336
[TBL] [Abstract][Full Text] [Related]
2. Modulation of cell adhesion and migration through regulation of the immunoglobulin superfamily member ALCAM/CD166.
von Lersner A; Droesen L; Zijlstra A
Clin Exp Metastasis; 2019 Apr; 36(2):87-95. PubMed ID: 30778704
[TBL] [Abstract][Full Text] [Related]
3. Modulation of activated leukocyte cell adhesion molecule-mediated invasion triggers an innate immune gene response in melanoma.
van Kilsdonk JW; Takahashi N; Weidle U; Burtscher H; Jarry J; Daha MR; Swart GW; van Kempen LC
J Invest Dermatol; 2012 May; 132(5):1462-70. PubMed ID: 22318386
[TBL] [Abstract][Full Text] [Related]
4. Shed urinary ALCAM is an independent prognostic biomarker of three-year overall survival after cystectomy in patients with bladder cancer.
Arnold Egloff SA; Du L; Loomans HA; Starchenko A; Su PF; Ketova T; Knoll PB; Wang J; Haddad AQ; Fadare O; Cates JM; Lotan Y; Shyr Y; Clark PE; Zijlstra A
Oncotarget; 2017 Jan; 8(1):722-741. PubMed ID: 27894096
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of melanoma invasion by a secreted variant of activated leukocyte cell adhesion molecule.
van Kilsdonk JW; Wilting RH; Bergers M; van Muijen GN; Schalkwijk J; van Kempen LC; Swart GW
Cancer Res; 2008 May; 68(10):3671-9. PubMed ID: 18483249
[TBL] [Abstract][Full Text] [Related]
6. ALCAM/CD166: A pleiotropic mediator of cell adhesion, stemness and cancer progression.
Ferragut F; Vachetta VS; Troncoso MF; Rabinovich GA; Elola MT
Cytokine Growth Factor Rev; 2021 Oct; 61():27-37. PubMed ID: 34272152
[TBL] [Abstract][Full Text] [Related]
7. Truncation of activated leukocyte cell adhesion molecule: a gateway to melanoma metastasis.
van Kempen LC; Meier F; Egeblad M; Kersten-Niessen MJ; Garbe C; Weidle UH; Van Muijen GN; Herlyn M; Bloemers HP; Swart GW
J Invest Dermatol; 2004 May; 122(5):1293-301. PubMed ID: 15140234
[TBL] [Abstract][Full Text] [Related]
8. Activated leukocyte cell adhesion molecule expression and shedding in thyroid tumors.
Miccichè F; Da Riva L; Fabbi M; Pilotti S; Mondellini P; Ferrini S; Canevari S; Pierotti MA; Bongarzone I
PLoS One; 2011 Feb; 6(2):e17141. PubMed ID: 21364949
[TBL] [Abstract][Full Text] [Related]
9. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.
Lunter PC; van Kilsdonk JW; van Beek H; Cornelissen IM; Bergers M; Willems PH; van Muijen GN; Swart GW
Cancer Res; 2005 Oct; 65(19):8801-8. PubMed ID: 16204050
[TBL] [Abstract][Full Text] [Related]
10. ALCAM regulates motility, invasiveness, and adherens junction formation in uveal melanoma cells.
Jannie KM; Stipp CS; Weiner JA
PLoS One; 2012; 7(6):e39330. PubMed ID: 22745734
[TBL] [Abstract][Full Text] [Related]
11. ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to bone.
Hansen AG; Arnold SA; Jiang M; Palmer TD; Ketova T; Merkel A; Pickup M; Samaras S; Shyr Y; Moses HL; Hayward SW; Sterling JA; Zijlstra A
Cancer Res; 2014 Mar; 74(5):1404-15. PubMed ID: 24385212
[TBL] [Abstract][Full Text] [Related]
12. The role of activated leukocyte cell adhesion molecule (ALCAM) in cancer progression, invasion, metastasis and recurrence: A novel cancer stem cell marker and tumor-specific prognostic marker.
Darvishi B; Boroumandieh S; Majidzadeh-A K; Salehi M; Jafari F; Farahmand L
Exp Mol Pathol; 2020 Aug; 115():104443. PubMed ID: 32380056
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of transcriptional regulation and prognostic significance of activated leukocyte cell adhesion molecule in cancer.
King JA; Tan F; Mbeunkui F; Chambers Z; Cantrell S; Chen H; Alvarez D; Shevde LA; Ofori-Acquah SF
Mol Cancer; 2010 Oct; 9():266. PubMed ID: 20929568
[TBL] [Abstract][Full Text] [Related]
14. Activated leukocyte cell adhesion molecule expression correlates with the WNT subgroup in medulloblastoma and is involved in regulating tumor cell proliferation and invasion.
Achiha T; Kijima N; Kodama Y; Kagawa N; Kinoshita M; Fujimoto Y; Nonaka M; Fukai J; Inoue A; Nishida N; Yamanaka T; Harada A; Mori K; Tsuyuguchi N; Uda T; Ishibashi K; Tomogane Y; Sakamoto D; Shofuda T; Yoshioka E; Kanematsu D; Mano M; Luu B; Taylor MD; Kanemura Y; Kishima H
PLoS One; 2020; 15(12):e0243272. PubMed ID: 33270750
[TBL] [Abstract][Full Text] [Related]
15. Molecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell function.
Ikeda K; Quertermous T
J Biol Chem; 2004 Dec; 279(53):55315-23. PubMed ID: 15496415
[TBL] [Abstract][Full Text] [Related]
16. Negatively charged amino acids in the stalk region of membrane proteins reduce ectodomain shedding.
Iwagishi R; Tanaka R; Seto M; Takagi T; Norioka N; Ueyama T; Kawamura T; Takagi J; Ogawa Y; Shirakabe K
J Biol Chem; 2020 Aug; 295(35):12343-12352. PubMed ID: 32580944
[TBL] [Abstract][Full Text] [Related]
17. Activated leukocyte cell adhesion molecule impacts on clinical wound healing and inhibits HaCaT migration.
Sanders AJ; Jiang DG; Jiang WG; Harding KG; Patel GK
Int Wound J; 2011 Oct; 8(5):500-7. PubMed ID: 21816001
[TBL] [Abstract][Full Text] [Related]
18. ALCAM/CD166: cancer-related issues.
Weidle UH; Eggle D; Klostermann S; Swart GW
Cancer Genomics Proteomics; 2010; 7(5):231-43. PubMed ID: 20952758
[TBL] [Abstract][Full Text] [Related]
19. Activated leukocyte cell-adhesion molecule (ALCAM) promotes malignant phenotypes of malignant mesothelioma.
Ishiguro F; Murakami H; Mizuno T; Fujii M; Kondo Y; Usami N; Yokoi K; Osada H; Sekido Y
J Thorac Oncol; 2012 May; 7(5):890-9. PubMed ID: 22722789
[TBL] [Abstract][Full Text] [Related]
20. Stromal Expression of Activated Leukocyte Cell Adhesion Molecule Promotes Lung Tumor Growth and Metastasis.
Willrodt AH; Beffinger M; Vranova M; Protsyuk D; Schuler K; Jadhav M; Heikenwalder M; van den Broek M; Borsig L; Halin C
Am J Pathol; 2017 Nov; 187(11):2558-2569. PubMed ID: 28822802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
